BOOK
Pathways To Global Health: Case Studies In Global Health Diplomacy - Volume 2
Matlin Stephen | Kickbusch Ilona
(2016)
Additional Information
Book Details
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Contents | vii | ||
Foreword | v | ||
1. Introduction: Charting Pathways in Global Health Diplomacy | 1 | ||
1. The Evolving Field of Global Health Diplomacy\r | 1 | ||
2. Global Health Diplomacy and the World Health Organization\r | 4 | ||
3. Introduction to the Case Studies | 7 | ||
4. Contributor’s Biographies | 11 | ||
References and Notes | 12 | ||
2. Negotiating the World Health Organization Reform Process | 15 | ||
1. Antecedents | 15 | ||
2. The Problem: Why the Ongoing Reform became Unavoidable\r | 16 | ||
3. The Reform Agenda in 2010 and Onwards | 18 | ||
4. What has been Achieved? | 20 | ||
5. Lessons Learned | 29 | ||
6. Conclusions | 32 | ||
7. Closing Remarks | 33 | ||
8. Acknowledgements | 33 | ||
9. Contributor’s Biography | 33 | ||
References and Notes | 34 | ||
3. How should the World Health Organization Reform? An Analysis and Review of the Literature\r | 39 | ||
1. Introduction | 39 | ||
2. What can we Learn from the Literature on WHO Reform?\r | 41 | ||
3. Detailed Literature Reviews | 49 | ||
3.1 Making the Case for Reform | 49 | ||
3.2 Focus and Balance | 54 | ||
3.3 Specific Proposals | 63 | ||
3.4 Insider Views | 77 | ||
4. Other Papers Considered for Analysis | 78 | ||
5. Contributors’ Biographies | 78 | ||
References and Notes | 80 | ||
4. Combating Antimicrobial Resistance: Building Consensus for Global Action\r | 89 | ||
1. The Problem | 89 | ||
2. Combating AMR — The Key Challenges | 92 | ||
3. Historical Context | 93 | ||
4. The Players and their Roles | 98 | ||
5. Getting AMR on the Agenda | 102 | ||
6. Building a Technical Consensus | 104 | ||
7. A Diplomatic Campaign | 106 | ||
8. Lessons Learned | 107 | ||
9. Conclusions | 108 | ||
10. Closing Remarks | 109 | ||
11. Contributors’ Biographies | 111 | ||
References and Notes | 112 | ||
5. The Global Poliomyelitis Eradication Initiative: The Role of Diplomacy in Reaching “The Last 1%”\r | 119 | ||
1. Context | 119 | ||
2. Players and their Roles | 122 | ||
3. Challenges Faced and Outcomes | 125 | ||
4. Conclusions and Overarching Lessons Learned | 135 | ||
5. Contributors’ Biographies | 136 | ||
References and Notes | 137 | ||
6. Information-Sharing and Disease Reporting in a New Era of International Frameworks and Communication Technology: Middle East Respiratory Syndrome Coronavirus and Ebola Virus Disease Outbreaks\r | 141 | ||
1. The Problem | 141 | ||
2. Players and their Roles | 143 | ||
2.1 Historical Communications | 143 | ||
2.2 Changes in Global Communication Technologies and Information Platforms | 144 | ||
2.3 How Communications Advances have Transformed Public Health | 145 | ||
3. Challenges Faced and Outcomes | 147 | ||
3.1 An impetus for Change: SARS | 147 | ||
3.2 IHR (2005): A New Framework for Information-Sharing | 148 | ||
3.3 To Declare or not to Declare: Public Health Emergencies of International Concern (PHEIC)\r | 150 | ||
3.4 Middle East Respiratory Syndrome — How to Share Information, and How Much?\r | 152 | ||
3.5 West Africa Ebola Virus Disease — Information-Sharing for International Response\r | 157 | ||
4. Lessons Learned | 162 | ||
5. Conclusion | 163 | ||
6. Contributors’ Biographies | 164 | ||
References and Notes | 165 | ||
7. Negotiation and Health Diplomacy: The Case of Tobacco | 171 | ||
Editors’ Note | 171 | ||
1. Multilateral and Multi-Stakeholder Negotiations: Overview of Key Concepts for this Case Study\r | 172 | ||
2. The Problem: Increasing Global Tobacco Consumption and Costs of Smoking for Economies and Societies\r | 174 | ||
2.1 Global Consumption of Cigarettes | 174 | ||
2.2 Costs to the Economy\r | 175 | ||
2.3 Costs to Society | 176 | ||
2.4 Tobacco Industry Marketing | 177 | ||
3. Negotiation of WHO Framework Convention on Tobacco Control and Related Protocols\r | 179 | ||
3.1 History of the Convention | 179 | ||
3.2 Protocol Negotiations under FCTC Articles 13 and 15\r | 180 | ||
4. Key Actors and their Roles: Framing Actors´ Interests in the FCTC Negotiation\r | 183 | ||
4.1 Non-State Actor Engagement in the FCTC | 183 | ||
4.2 International NGO Groups and Alliances | 185 | ||
4.3 World Health Organization | 188 | ||
4.4 Key Country/Government Actors | 190 | ||
4.5 Tobacco Industry Transnational Corporations | 190 | ||
5. Linkages to Other International Agreements and Tobacco-Related Government Actions \rOutside the FCTC | 197 | ||
6. Conclusions and Future Challenges | 199 | ||
7. Acknowledgments | 201 | ||
8. Contributors’ Biographies | 201 | ||
References and Notes | 202 | ||
8. Tobacco Plain Packaging, the World Trade Organization, and the World Health Organization Framework Convention on Tobacco Control | 211 | ||
1. Introduction | 211 | ||
2. A Critical Test for Global Health Governance | 211 | ||
3. Global Health Governance: Tobacco and NCDS | 213 | ||
4. The WTO Challenges in the Context of Legal Challenges to Tobacco Control | 220 | ||
5. The FCTC, the COP, and the Governance of Health and Trade | 226 | ||
6. Conclusion | 238 | ||
7. Postscript | 239 | ||
8. Contributors’ Biographies | 241 | ||
References and Notes | 242 | ||
9. Positioning Women’s and Children’s Health in the Post-2015 Sustainable Development Agenda\r | 253 | ||
1. The Problem | 253 | ||
2. Background | 255 | ||
2. Women’s and Children’s Health and the Post-2015 Development Agenda | 259 | ||
3. Lessons Learned | 278 | ||
4. Conclusions | 283 | ||
5. Contributors’ Biographies | 284 | ||
References and Notes | 285 | ||
10. Negotiating the Sustainable Development Goals: The Role of Non-State Actors\r | 295 | ||
1. Setting the Scene | 295 | ||
2. The Open Working Group and the Subsequent Informal Inter-Governmental Negotiations\r | 299 | ||
3. What Worked Well and Less Well | 306 | ||
4. Lessons Learned | 307 | ||
5. Conclusion | 308 | ||
6. Contributor’s Biography | 309 | ||
References and Notes | 309 | ||
11. Conclusions: Shifting Pathways in Global Health Diplomacy | 313 | ||
1. Following Pathways of Global Health Diplomacy\r | 313 | ||
2. Global Health Diplomacy and WHO | 314 | ||
3. Achieving Action on a Critical Health Issue | 318 | ||
Reinforcing the End Stages of a Global Public Health Campaign\r | 321 | ||
5. New Venues and Modalities in Health Diplomacy\r | 324 | ||
6. Diversification of Actors and their Roles in Health Negotiations\r | 330 | ||
7. Positioning Health Issues in Sustainable Development\r | 336 | ||
8. Conclusions | 341 | ||
9. Contributor’s Biographies | 348 | ||
References and Notes | 350 | ||
Index | 351 |